TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Gross Motor Function Measure -total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement of postoperative pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidents of variceal hemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidents of ascites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Hepatic Encephalopathy (HE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes of islet secretory function (HOMA-β)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Maudsley 3-item Visual Analogue Scale (M3VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in score on the Leicester Cough Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Exophthalmometry Value (EVP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Beliefs About Aggression and Alternatives (BAA)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Engagement in Community Advocacy
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Risk of anal dysplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: HPV (Human Papillomavirus) status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Skin Carotenoid Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Changes in VOC Patterns over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation between blood glucose and patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Brief Symptom Inventory-18 (BSI-18)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived Stress Scale - 10 Items (PSS-10)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Positive Aspects of Caregiving (PAC)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Progression in total cerebral small vessel disease burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Frequency of stroke recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Change in periodontal parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement between lab-derived and Hb Scope-derived Hb level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Tissue distribution of [18F]-DEVD-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number/% of subjects achieving SpO2 ≥90% for >30% of sleep time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: URTI incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: number of URTI incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Diaphragm Thickness Measurement at Quiet Breathing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Exercise Capacity Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mask pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in glycated haemoglobin A1c (HbA1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Nature Connection Index
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Center for Epidemiological Studies Depression (CES-D)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Parkinson's Disease Sleep Scale-2
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Task performance (dexterity)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to physical activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Discriminability, d'
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inspiratory capacity during exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Increase in intraocular pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Narrowing of the eye angles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Increase in pupil diameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Change of cognitive function composite
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in breathlessness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number Post-operative complications
Endpoint domain: Adverse events/effects
Primary endpoint: Change in microbiome function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mortality of patients with severe trauma
Endpoint domain: Mortality/survival
Primary endpoint: Pain during tooth extraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Loss of predicted bilirubin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Titers for Hemagglutination Inhibition (HI) Antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: RSV-A Neutralizing Antibody Titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in peripheral blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Failure of conservative treatment
Endpoint domain: Adverse events/effects
Primary endpoint: ST2 level in the acute phase after myocardial infarction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Ocular hypotensive efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of referred patients who are eligible to enroll
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of patients who complete both the baseline and 3 month follow-up survey
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of participants who complete the surveys
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Sling satisfaction survey
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Pelvic Pain Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Kinesiophobia and Pain Catastrophizing
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of Heartburn Episodes Completely Relieved
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Breastfeeding problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Trunk endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom Index
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Positive predictive value of Transpara® scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Response to treatments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of pathological complete response (PCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neutropenia (CTCAE grade)
Endpoint domain: Adverse events/effects
Primary endpoint: Peripheral neuropathy (CTCAE grade)
Endpoint domain: Adverse events/effects
Primary endpoint: diaphragmatic longitudinal strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: diaphragmatic longitudinal strain rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of post-MI angina
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Extent of coronary atherosclerosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: New fractures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Location of fractures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Timing of fractures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Total Dose per 4 weeks
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Total Infusion Volume per 4 Weeks
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Treatment Interval per 4 Weeks
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Participants Categorized by Local Tolerability Score
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum Local Tolerability Signs Total Composite Score Post Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Time to Maximum Local Tolerability Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Freedom from documented AF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Sensitivity and specificity of Truenat™ MTB Plus/COVID-19
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: UPSIT score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nail fungal infection clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Biomarker change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes to treatment intent and/or plan
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of patients who complete 2 VR sessions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of patients reporting ease of use for VR sessions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of overall adherence to radiation therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Acceptability Scale scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: System Usability Scale scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean caregiver satisfaction scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient satisfaction measures
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Central auditory processing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Substance specific craving
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Social and Occupational Functioning
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: MTD based on number of dose-limiting toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Determine Recommended Phase 2 Dose (RP2D)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Adverse Events [Safety and tolerability]
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in end expiratory lung volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Participant satisfaction with the app
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Assessment of app appropriateness for managing cravings, stress, and anxiety
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Assessment of app ease and practicality of use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Renal regional tissue oxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: soft tissue sinking of the recipient vessels area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement of magnetic resonance imaging (MRI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: First Occurrence of COVID-19 of Any Severity
Endpoint domain: Mortality/survival
Primary endpoint: Solicited Local and Systemic Adverse Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Non-inferiority of the neutralizing titers after third dose compared to the second dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sensitivity index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concordance of blood type results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Insertion to delivery time interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: In-hospital infection
Endpoint domain: Adverse events/effects
Primary endpoint: recruitment rate (percentage)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: recruitment rate (total number per month)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Loneliness Scale for Elderly
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Life Satisfaction Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Spatial pattern and extent of T-N Mismatch
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in C-Reactive Protein (CRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Brief Negative Symptom Scale (BNSS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in diaphragmatic excursion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Arterial Blood gases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in capacity to perform daily activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Intraocular Pressure Measurement (IOP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Grading of Retinal Vascular Diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Visual Contrast Sensitivity Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Change in availability of healthy and unhealthy food options
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: L-Carnitine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in drainage, erythema, oedema, and pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Presence of intact tissues associated with the wound
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Concentration of molecules relating to energy metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of eligible women selecting outpatient labor induction
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Fetal metabolic acidosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Deliveries outside the hospital
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Number of Participants With Stage 2 Hypertension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maximum isometric force developed in the quadriceps
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: White matter integrity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cerebral activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 2 year event-free survival (EFS) rate
Endpoint domain: Mortality/survival
Primary endpoint: Reduction of serum potassium level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Maximum concentration (Cmax) of Midazolam and its metabolite 1'-OH-midazolam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve (AUC0-t) of Midazolam and its metabolite 1'-OH-midazolam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC extrapolated to infinity (AUCinf) of Midazolam and its metabolite 1'-OH-midazolam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of patients with successful pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Domain-specific Cognition
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: 24 hour urine carbamide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: NIDCAP Organizational Structures Assessment
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Percentage of patients that will complete the study
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Saliva Sample Cortisol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Proportion of Participants with PSMA-Positive Lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Participants Diagnosed with Stroke at 3 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Participants Diagnosed with Myocardial Infarction (MI) at 3 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants who Died from Cardiovascular Causes at 3 Months
Endpoint domain: Mortality/survival
Primary endpoint: Cardiac MRI (CMR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Perceived changes in mental health symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived changes in stress management
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 90 day modified Rankin Scale (mRS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Successful % of bowel preparation before colonoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Retention rate in study
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: sensitivity of TB-IGRA 2nd generation test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: specificity of TB-IGRA 2nd generation test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Power spectral density in the frequency of motor imagery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Prevalence of bacterial isolation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: MLYMT scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: MLSDT scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Alcohol Use Disorders Identification Test (AUDIT) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change in Participants Determined to be High-Risk for SUD per TAPS Screening Tool
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnosis of colorectal carcinoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Prognosis of colorectal carcinoma
Endpoint domain: Mortality/survival
Primary endpoint: Change in smoking craving on Visual Analog Scale at week 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in smoking craving on Visual Analog Scale at week 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in orexin level at 24 hours after extinction training
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional and genomic profiling of glioblastoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: serum ACE levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: serum ACE2 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Subjective fear
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Subjective disgust
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: complaints of discomfort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: plasma ghrelin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Child Self-Regulation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing